No Data
Chengdu Bright Eye Hospital Group Co., Ltd. (SZSE:301239) Insiders, Who Hold 44% of the Firm Would Be Disappointed by the Recent Pullback
Puri Ophthalmology: Report for the third quarter of 2024
Purui Ophthalmology (301239.SZ) released its performance for the first three quarters, with a net income of 15.8412 million yuan, a decrease of 95.01%.
PRICON Ophthalmology (301239.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 2...
Purui Ophthalmology (301239.SZ): The net income for the first three quarters was 15.8412 million yuan, a year-on-year decrease of 95.01%.
Gelonghui October 29th | Prui Ophthalmology (301239.SZ) released the third quarter report of 2024, with the company achieving revenue of 2.137 billion yuan in the first three quarters, a year-on-year decrease of 1.36%; net income attributable to shareholders of the listed company was 15.8412 million yuan, a year-on-year decrease of 95.01%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 18.3133 million yuan, a year-on-year decrease of 92.04%; basic earnings per share was 0.11 yuan.
Is Chengdu Bright Eye Hospital Group (SZSE:301239) Using Too Much Debt?
Puri Ophthalmology: 2024 Semi-Annual Report Summary
The Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Don't Inspire Confidence
No Data
